COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance by Suzanne C. Cannegieter, Frederikus A. Klok

Get full text

Using real-world evidence to complement evidence from randomized controlled trials on oral anticoagulants for stroke prevention. by Mark J R Smeets, Suzanne C Cannegieter

Get full text

High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander? by Anja J.M. Schreijer, Pieter H. Reitsma, Suzanne C. Cannegieter

Get full text

Sex‐specific aspects of venous thromboembolism: What is new and what is next? by Luuk J. J. Scheres, Astrid vanHylckama Vlieg, Suzanne C. Cannegieter

Get full text

Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk by Suely Meireles Rezende, Willem M. Lijfering, Frits R. Rosendaal, Suzanne C. Cannegieter

Get full text

Tutorial: dos and don’ts in clinical prediction research for venous thromboembolism by Banne Nemeth, Mark J.R. Smeets, Suzanne C. Cannegieter, Maarten van Smeden

Get full text

Direct factor Xa inhibitors and the risk of cancer and cancer mortality: A Danish population-based cohort study. by Floris Bosch, Erzsébet Horváth-Puhó, Suzanne C Cannegieter, Nick van Es, Henrik T Sørensen

Get full text

Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. by Linda E Flinterman, Astrid van Hylckama Vlieg, Suzanne C Cannegieter, Frits R Rosendaal

Get full text

Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique by Kirsten van Langevelde, Alexandr Šrámek, Patrice W.J. Vincken, Jan-Kees van Rooden, Frits R. Rosendaal, Suzanne C. Cannegieter

Get full text

Estimating incidence of venous thromboembolism in COVID‐19: Methodological considerations by Linda Nab, Rolf H. H. Groenwold, Frederikus A. Klok, Soerajja Bhoelan, Marieke J. H. A. Kruip, Suzanne C. Cannegieter

Get full text

Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study by Eng Soo Yap, Willem M. Lijfering, Jasmijn F. Timp, Frits R. Rosendaal, Suzanne C. Cannegieter, Luuk J. J. Scheres

Get full text

Validation of the 5-SNP score for the prediction of venous thromboembolism in a Danish fast-track cohort of 6789 total hip and total knee arthroplasty patients by Mark J.R. Smeets, Pelle B. Petersen, Christoffer C. Jørgensen, Suzanne C. Cannegieter, Sisse R. Ostrowski, Henrik Kehlet, Banne Nemeth

Get full text

Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2) by Petter Quist-Paulsen, Inger Anne Næss, Suzanne C. Cannegieter, Pål R. Romundstad, Sverre C. Christiansen, Frits R. Rosendaal, Jens Hammerstrøm

Get full text

External validation of the Leiden Thrombosis Recurrence Risk Prediction models (L-TRRiP) for the prediction of recurrence after a first venous thrombosis in the Heart and Vascular... by J. Louise I. Burggraaf-van Delft, Kerri L. Wiggins, Nienke van Rein, Saskia le Cessie, Nicholas L. Smith, Suzanne C. Cannegieter

Get full text

Changes in incidence of hospitalization for cardiovascular diseases during the COVID-19 pandemic in The Netherlands in 2020 by Eva K. Kempers, Qingui Chen, Chantal Visser, Eric C. M. van Gorp, Frederikus A. Klok, Suzanne C. Cannegieter, Marieke J. H. A. Kruip

Get full text

Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy by Carolina E. Touw, Banne Nemeth, Raymond A. van Adrichem, Astrid van Hylckama Vlieg, Rob G. H. H. Nelissen, Ton Lisman, Suzanne C. Cannegieter

Get full text

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis by Eleonora Camilleri, Nienke van Rein, Felix J. M. van der Meer, Melchior C. Nierman, Willem M. Lijfering, Suzanne C. Cannegieter, The Dutch COVID & Thrombosis Coalition

Get full text

Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism by Sake J. van der Wall, Frederikus A. Klok, Paul L. den Exter, Deisy Barrios, Raquel Morillo, Suzanne C. Cannegieter, David Jimenez, Menno V. Huisman

Get full text

Tumor‐expressed microRNAs associated with venous thromboembolism in colorectal cancer by Rayna J. S. Anijs, El Houari Laghmani, Betül Ünlü, Szymon M. Kiełbasa, Hailiang Mei, Suzanne C. Cannegieter, Frederikus A. Klok, Peter J. K. Kuppen, Henri H. Versteeg, Jeroen T. Buijs

Get full text

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants by Myrthe M. A. Toorop, Nienke vanRein, Melchior C. Nierman, Helga W. Vermaas, Menno V. Huisman, Felix J. M. van derMeer, Suzanne C. Cannegieter, Willem M. Lijfering

Get full text